☰

Warren B. Bilker - Publications

Affiliations: 
Epidemiology and Biostatistics University of Pennsylvania, Philadelphia, PA, United States 
Area:
Biostatistics Biology, Statistics
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, et al. Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Transmission Within and Between Regional Long-Term Acute Care Hospitals. Antimicrobial Agents and Chemotherapy. PMID 31451495 DOI: 10.1128/Aac.01622-19  0.301
2017 Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH. Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children: a Multicenter Study. Antimicrobial Agents and Chemotherapy. PMID 28971864 DOI: 10.1128/Aac.01440-17  0.337
2016 Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Wheeler M, Tolomeo P, Han JH. Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae. Infection Control and Hospital Epidemiology. 1-7. PMID 27678022 DOI: 10.1017/Ice.2016.225  0.304
2015 Han JH, Nachamkin I, Coffin SE, Gerber JS, Fuchs B, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Lautenbach E. Use of a combination biomarker algorithm to identify medical intensive care unit patients with suspected sepsis at very low likelihood of bacterial infection. Antimicrobial Agents and Chemotherapy. PMID 26239984 DOI: 10.1128/Aac.00958-15  0.305
2015 Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, et al. Risk Factors for Recurrent Colonization With Methicillin-Resistant Staphylococcus aureus in Community-Dwelling Adults and Children. Infection Control and Hospital Epidemiology. 36: 786-93. PMID 25869756 DOI: 10.1017/Ice.2015.76  0.317
2015 Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study. The Journal of Antimicrobial Chemotherapy. 70: 1547-51. PMID 25630645 DOI: 10.1093/Jac/Dku548  0.303
2013 Han JH, Bilker WB, Nachamkin I, Tolomeo P, Mao X, Fishman NO, Lautenbach E. Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility. Infection Control and Hospital Epidemiology. 34: 1070-6. PMID 24018924 DOI: 10.1086/673155  0.316
2012 Han JH, Mascitti KB, Edelstein PH, Bilker WB, Lautenbach E. Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy. 56: 5164-70. PMID 22825122 DOI: 10.1128/Aac.00757-12  0.313
2011 Akhabue E, Synnestvedt M, Weiner MG, Bilker WB, Lautenbach E. Cefepime-resistant Pseudomonas aeruginosa. Emerging Infectious Diseases. 17: 1037-43. PMID 21749765 DOI: 10.3201/Eid/1706.100358  0.308
2011 Rattanaumpawan P, Tolomeo P, Bilker WB, Fishman NO, Lautenbach E. Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. Epidemiology and Infection. 139: 955-61. PMID 20696087 DOI: 10.1017/S095026881000186X  0.323
2010 Rattanaumpawan P, Tolomeo P, Bilker WB, Fishman NO, Lautenbach E. Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections. The Journal of Hospital Infection. 76: 324-7. PMID 20643497 DOI: 10.1016/J.Jhin.2010.05.023  0.315
2009 Lautenbach E, Metlay JP, Weiner MG, Bilker WB, Tolomeo P, Mao X, Nachamkin I, Fishman NO. Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infection Control and Hospital Epidemiology. 30: 18-24. PMID 19046057 DOI: 10.1086/592703  0.307
2008 Schelleman H, Bilker WB, Brensinger CM, Han X, Kimmel SE, Hennessy S. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: Interactions and the risk of hospitalization for gastrointestinal bleeding Clinical Pharmacology and Therapeutics. 84: 581-588. PMID 18685566 DOI: 10.1038/Clpt.2008.150  0.307
2007 Gasink LB, Zaoutis TE, Bilker WB, Lautenbach E. The categorization of prior antibiotic use: impact on the identification of risk factors for drug resistance in case control studies. American Journal of Infection Control. 35: 638-42. PMID 18063127 DOI: 10.1016/J.Ajic.2007.01.011  0.301
2007 Gasink LB, Fishman NO, Nachamkin I, Bilker WB, Lautenbach E. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa Infection Control and Hospital Epidemiology. 28: 1175-1180. PMID 17828695 DOI: 10.1086/520740  0.323
2007 Hyle EP, Bilker WB, Gasink LB, Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection Infection Control and Hospital Epidemiology. 28: 647-654. PMID 17520535 DOI: 10.1086/516798  0.304
2006 Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among Pseudomonas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes Infection Control and Hospital Epidemiology. 27: 893-900. PMID 16941312 DOI: 10.1086/507274  0.317
2006 MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use International Journal of Antimicrobial Agents. 28: 325-332. PMID 16934439 DOI: 10.1016/J.Ijantimicag.2006.04.014  0.309
2006 Gasink LB, Fishman NO, Weiner MG, Nachamkin I, Bilker WB, Lautenbach E. Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact American Journal of Medicine. 119. PMID 16750968 DOI: 10.1016/J.Amjmed.2005.11.029  0.318
2005 Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing enterobacteriaceae: Variability by site of infection Archives of Internal Medicine. 165: 1375-1380. PMID 15983286 DOI: 10.1001/Archinte.165.12.1375  0.317
2005 Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species Clinical Infectious Diseases. 40: 1317-1324. PMID 15825035 DOI: 10.1086/429239  0.318
2004 Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia Pediatric Infectious Disease Journal. 23: 635-641. PMID 15247602 DOI: 10.1097/01.Inf.0000128781.77600.6F  0.307
2003 Gur RE, Kohler C, Ragland JD, Siegel SJ, Bilker WB, Loughead J, Phend N, Gur RC. Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2029-36. PMID 12902996 DOI: 10.1038/Sj.Npp.1300275  0.303
2001 Gur RC, Ragland JD, Moberg PJ, Bilker WB, Kohler C, Siegel SJ, Gur RE. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 777-88. PMID 11682261 DOI: 10.1016/S0893-133X(01)00279-2  0.3
2001 Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae Clinical Infectious Diseases. 33: 1288-1294. PMID 11565067 DOI: 10.1086/322667  0.31
1999 Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality Infection Control and Hospital Epidemiology. 20: 318-323. PMID 10349947 DOI: 10.1086/501624  0.326
1998 Lautenbach E, Schuster MG, Bilker WB, Brennan PJ. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus Clinical Infectious Diseases. 27: 1259-1265. PMID 9827280 DOI: 10.1086/515002  0.31
1998 Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry. 55: 145-52. PMID 9477928 DOI: 10.1001/Archpsyc.55.2.145  0.303
1994 Haro JM, Eaton WW, Bilker WB, Mortensen PB. Predictability of rehospitalization for schizophrenia European Archives of Psychiatry and Clinical Neuroscience. 244: 241-246. PMID 7893769 DOI: 10.1007/Bf02190376  0.312
Show low-probability matches.